Targeted Strategies for Today's Evolving Markets

MissionIR Blog

MissionIRNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Plans to Release Q1 2021 Results on May 17

DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, plans to release financial results for first-quarter 2021, the period ended March 31, 2021. The company will release its report after market close on Monday, May 17, 2021. In addition, the company announced that it has scheduled a conference call and webcast to discuss the report; that event is slated for Tuesday, May 18, 2021, at 8:30 a.m. ET. DRIO executives will host the call; those executives include CEO Erez Raphael, president and NA general manager Rick Anderson, and chief financial officer Zvi Ben-David. Those who want to participate on the call are encouraged to dial in 10 minutes before the call is scheduled to being. Callers can dial 1-877-451-6152 domestically or 1-201-389-0879 internationally; conference ID is DarioHealth First Quarter 2021 Results Call. In addition, a webcast archive replay of the call will be available for two months after the call.

To attend the conference via webcast, register at

To view the full press release, visit

About DarioHealth Corp.

DarioHealth Corp. is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. Dario’s next-generation, AI-powered, digital therapeutic solutions support more than just an individual’s disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions, intuitive, clinically proven digital tools, high-quality software and coaching to help individuals improve health and sustain meaningful outcomes. Dario offers one of the highest-rated diabetes and hypertension solutions on the market. The company’s cross-functional team operates at the intersection of life sciences, behavioral science, and software technology and is rapidly expanding into new chronic conditions and geographic markets, using a performance-based approach to improve its users’ health. Dario makes the right thing to do the easy thing to do. For more information about the company, please visit

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published:

This entry was posted in DarioHealth Corp. DRIO, MissionIRNewsBreaks. Bookmark the permalink.

Comments are closed.